Clinical Trials › NCT07008378
RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, and Pharmacodynamics of P-CD19CD20-ALLO1 in Participants With Multiple Sclerosis
Sponsored by Genentech, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 60
Target enrollment
1
U.S. states
Oct 2025
Start date
Aug 2032
Expected completion
Interventions / Treatments
P-CD19CD20-ALLO1 CellsCyclophosphamideFludarabine
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Missouri1 site
St Louis
Participating MS centers on MS Buddy (1)
John L. Trotter Multiple Sclerosis Center
Saint Louis, MO
Saint Louis, MO
MS centers in Missouri
Compare treatment centers near a trial site by center type, providers and trials.
View Missouri centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.